389 related articles for article (PubMed ID: 27577081)
1. DNA methylation array analysis identifies breast cancer associated RPTOR, MGRN1 and RAPSN hypomethylation in peripheral blood DNA.
Tang Q; Holland-Letz T; Slynko A; Cuk K; Marme F; Schott S; Heil J; Qu B; Golatta M; Bewerunge-Hudler M; Sutter C; Surowy H; Wappenschmidt B; Schmutzler R; Hoth M; Bugert P; Bartram CR; Sohn C; Schneeweiss A; Yang R; Burwinkel B
Oncotarget; 2016 Sep; 7(39):64191-64202. PubMed ID: 27577081
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation array analyses identified breast cancer-associated HYAL2 methylation in peripheral blood.
Yang R; Pfütze K; Zucknick M; Sutter C; Wappenschmidt B; Marme F; Qu B; Cuk K; Engel C; Schott S; Schneeweiss A; Brenner H; Claus R; Plass C; Bugert P; Hoth M; Sohn C; Schmutzler R; Bartram CR; Burwinkel B
Int J Cancer; 2015 Apr; 136(8):1845-55. PubMed ID: 25213452
[TBL] [Abstract][Full Text] [Related]
3. RPTOR methylation in the peripheral blood and breast cancer in the Chinese population.
Yin Y; Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Li H; Gu W; Ma F; Yang R; Zhang Z
Genes Genomics; 2022 Apr; 44(4):435-443. PubMed ID: 34767153
[TBL] [Abstract][Full Text] [Related]
4. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
5. The association between RAPSN methylation in peripheral blood and breast cancer in the Chinese population.
Lei S; Li L; Yang X; Yin Q; Xu T; Zhou W; Gu W; Ma F; Yang R
J Hum Genet; 2021 Nov; 66(11):1069-1078. PubMed ID: 33958711
[TBL] [Abstract][Full Text] [Related]
6. The association between breast cancer and S100P methylation in peripheral blood by multicenter case-control studies.
Yang R; Stöcker S; Schott S; Heil J; Marme F; Cuk K; Chen B; Golatta M; Zhou Y; Sutter C; Wappenschmidt B; Schmutzler R; Bugert P; Qu B; Bartram CR; Sohn C; Schneeweiss A; Burwinkel B
Carcinogenesis; 2017 Mar; 38(3):312-320. PubMed ID: 28426874
[TBL] [Abstract][Full Text] [Related]
7. Hypomethylation of RPTOR in peripheral blood is associated with very early-stage lung cancer.
Zhu Q; Qiao R; Di F; Song Y; Zhang J; Xu T; Wang Y; Dai L; Gu W; Han B; Yang R
Clin Chim Acta; 2022 Dec; 537():173-180. PubMed ID: 36332669
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of peripheral blood DNA methylation at RPTOR, MGRN1 and RAPSN and risk of breast cancer.
Dugué PA; Milne RL; Southey MC
Breast Cancer Res Treat; 2017 Jan; 161(1):181-183. PubMed ID: 27778206
[No Abstract] [Full Text] [Related]
9. Circulating cell-free DNA-based epigenetic assay can detect early breast cancer.
Uehiro N; Sato F; Pu F; Tanaka S; Kawashima M; Kawaguchi K; Sugimoto M; Saji S; Toi M
Breast Cancer Res; 2016 Dec; 18(1):129. PubMed ID: 27993161
[TBL] [Abstract][Full Text] [Related]
10. Blood-based DNA methylation as biomarker for breast cancer: a systematic review.
Tang Q; Cheng J; Cao X; Surowy H; Burwinkel B
Clin Epigenetics; 2016; 8():115. PubMed ID: 27895805
[TBL] [Abstract][Full Text] [Related]
11. Blood DNA methylation and breast cancer risk: a meta-analysis of four prospective cohort studies.
Bodelon C; Ambatipudi S; Dugué PA; Johansson A; Sampson JN; Hicks B; Karlins E; Hutchinson A; Cuenin C; Chajès V; Southey MC; Romieu I; Giles GG; English D; Polidoro S; Assumma M; Baglietto L; Vineis P; Severi G; Herceg Z; Flanagan JM; Milne RL; Garcia-Closas M
Breast Cancer Res; 2019 May; 21(1):62. PubMed ID: 31101124
[TBL] [Abstract][Full Text] [Related]
12. Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study.
Xu Z; Sandler DP; Taylor JA
J Natl Cancer Inst; 2020 Jan; 112(1):87-94. PubMed ID: 30989176
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
14. Epigenome-wide methylation in DNA from peripheral blood as a marker of risk for breast cancer.
Severi G; Southey MC; English DR; Jung CH; Lonie A; McLean C; Tsimiklis H; Hopper JL; Giles GG; Baglietto L
Breast Cancer Res Treat; 2014 Dec; 148(3):665-73. PubMed ID: 25407397
[TBL] [Abstract][Full Text] [Related]
15. DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.
Pronina IV; Loginov VI; Burdennyy AM; Fridman MV; Senchenko VN; Kazubskaya TP; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2017 Mar; 604():1-8. PubMed ID: 27998789
[TBL] [Abstract][Full Text] [Related]
16. Individual and joint performance of DNA methylation profiles, genetic risk score and environmental risk scores for predicting breast cancer risk.
Guan Z; Raut JR; Weigl K; Schöttker B; Holleczek B; Zhang Y; Brenner H
Mol Oncol; 2020 Jan; 14(1):42-53. PubMed ID: 31677238
[TBL] [Abstract][Full Text] [Related]
17. Normal breast tissue DNA methylation differences at regulatory elements are associated with the cancer risk factor age.
Johnson KC; Houseman EA; King JE; Christensen BC
Breast Cancer Res; 2017 Jul; 19(1):81. PubMed ID: 28693600
[TBL] [Abstract][Full Text] [Related]
18. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
20. Screening of significantly hypermethylated genes in breast cancer using microarray-based methylated-CpG island recovery assay and identification of their expression levels.
Lian ZQ; Wang Q; Li WP; Zhang AQ; Wu L
Int J Oncol; 2012 Aug; 41(2):629-38. PubMed ID: 22581028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]